Acute Lymphoblastic Leukemia/Acute Myeloid Leukemia

Latest News

FDA approved. | Image Credit: Pawel - stock.adobe.com
Treosulfan Regimen Approved for Allo-HSCT Conditioning in AML/MDS

January 23rd 2025

The FDA approved treosulfan in combination with fludarabine as preparation for allogeneic hematopoietic stem cell transplantation (allo-HSCT) in adult and pediatric patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).

Studies presented at ASH 2024 added to the understanding of real-world treatment and outcomes for patients with pediatric AML. | Image credit: LASZLO - stock.adobe.com
Studies Examine Real-World Pediatric AML Treatment and Outcomes

January 7th 2025

Jennifer Vaughn, MD, smiling during a zoom interview
The Balance of Managing Younger Patients With MPNs for Long-Term Treatment

December 26th 2024

Older patients with AML or MDS do not always receive the same care recommendations, a study found | image credit: Orawan - stock.adobe.com
Canadian Study Highlights Care Variability for Older Patients With MDS/AML

December 19th 2024

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo